(Q30777774)

English

Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

author name string

Shang-Rong Ji

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Yi Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sen-fang Sui

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

language of work or name

0 references

publication date

10 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

6273-6279

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Regulation of amyloid precursor protein cleavage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

alpha2-macroglobulin in late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Fibrillar Alzheimer's amyloid peptide Abeta(1-42) stimulates low density lipoprotein binding and cell association, free radical production and cell cytotoxicity in PC12 cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Denaturation studies of active-site labeled papain using electron paramagnetic resonance and fluorescence spectroscopy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

The specific interaction of myelin basic protein with lipids at the air-water interface

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Relation between various phospholipase actions on human red cell membranes and the interfacial phospholipid pressure in monolayers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Cholesterol-induced interfacial area condensations of galactosylceramides and sphingomyelins with identical acyl chains

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Cholesterol and the cell membrane

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Rapid isolation of neuroblastoma plasma membranes on Percoll gradients. Characterization and lipid composition.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Fluidity characteristics of bovine thyroid plasma membranes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Membrane cholesterol dynamics: cholesterol domains and kinetic pools

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Membrane-induced conformational change of proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Structure of the Alzheimer beta-amyloid peptide (25-35) and its interaction with negatively charged phospholipid vesicles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Calculation of protein conformation from circular dichroism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Cholesterol domains in biological membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104146200

21 January 2018

Identifiers

10.1074/JBC.M104146200

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30777774&oldid=1547433761"